1. 1.Calabresi P.. In: . ed. Philadelphia Pc. Multiple sclerosis and demyelinating conditions of the central nervous system. In: Goldman L AD, eds. Cecil Medicine, editor. Cecil Medicine. 24 ed. Philadelphia, Pa: Saunders Elsevier; 2012.
2.Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. The New England journal of medicine. 2000;343 (13):938-52.
3.David A. Greenberg MJA, Roger P. Simon,. Clinical Neurology. 8, editor: McGraw Hill Professional, 2012. 400 pages p.
4.Elhami SR, Mohammad K, Sahraian MA, Eftekhar H. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology. 2011; 36 (3):141-7.
5.Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Multiple sclerosis (Houndmills, Basingstoke, England). 2011;17(8):1022-7.
6.Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiple sclerosis in southeastern Iran. Clinical neurology and neurosurgery. 2013;115 (3):304-8.
7.Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. European neurology. 2010;64 (6):331-6.
8.Multiple sclerosis PubMed Health: U.S. National Library of Medicine; 2011. Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001747/#disclaimer.
9.Charcot JM. Lectures on the Diseases of the Nervous System: Delivered at la Salpêtrière: Henry C. Lea; 1879.
10.Butler MA, Bennett TL. In search of a conceptualization of multiple sclerosis: a historical perspective. Neuropsychology review. 2003;13 (2):93-112.
11.Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific TH1 responses in multiple sclerosis. Archives of Neurology. 2001;58 (7):1081.
12. Multiple sclerosis Society of Canada Canada
2014.Available from: mssociety.ca/en/information/symptoms_mng_depress.htm.
13.Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. American Journal of Psychiatry. 2002;159 (11):1862-8.
14.Patten SB, Metz LM. Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS Trial. Neurology. 2002;59 (5):744-6.
15.Siegert R, Abernethy D. Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery & Psychiatry. 2005;76 (4):469-75.
16.Gay MC, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta neurologica Scandinavica. 2010;121 (3):161-70.
17.Mattioli F, Bellomi F, Stampatori C, Parrinello G, Capra R. Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2011;32 (5):825-32.
18.Seyed Saadat SM, Hosseininezhad M, Bakhshayesh B, Seyed Saadat SN, Nabizadeh SP. Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013.
19.McGuigan C, Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. Journal of neurology. 2006; 253 (2):219-23.
20.Neil Lava. Multiple Sclerosis and Depression 2013. Available from: http://www.webmd.com/multiple-sclerosis/guide/ms-depression?bookmark=true&login=true&pin=false.
21.Nykiel P. Examination of the Psychometric Properties of the Beck Depression Inventory-II: Using the Rasch Measurement Model: ProQuest; 2007.
22.Bamer AM, Cetin K, Johnson KL, Gibbons LE, Ehde DM. Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis. General hospital psychiatry. 2008;30 (4):311-7.
23.Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple sclerosis (Houndmills, Basingstoke, England). 2007;13 (1):67-72.
24.Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, et al. Depression and anxiety amongst multiple sclerosis patients. European journal of neurology : the official journal of the European Federation of Neurological Societies. 2008;15 (3):239-45.
25.Sajjadi H, Mohaqeqi Kamal SH, Rafiey H, Vameghi M, Forouzan AS, Rezaei M. A systematic review of the prevalence and risk factors of depression among iranian adolescents. Global journal of health science. 2013;5 (3):16-27.
26.Joffe RT. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9 ed: Kaplan and Sadock's Comprehensive Textbook of Psychiatry; 2009 June 8, 2009.
27.Labuz-Roszak B, Kubicka-Baczyk K, Pierzchala K, Machowska-Majchrzak A, Skrzypek M. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis. Neurologia i neurochirurgia polska. 2012;46 (4):309-17.
28.Williams RM, Turner AP, Hatzakis M, Jr., Bowen JD, Rodriquez AA, Haselkorn JK. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology. 2005;64 (1):75-80.
29.Feinstein A. Multiple sclerosis and depression. Multiple Sclerosis Journal. 2011;17 (11):1276-81.
|